January 11, 2024
Praxis Precision Medicines, Inc. Announces Pricing of $150.0 Million Public Offering
January 10, 2024
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
January 8, 2024
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
January 5, 2024
Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China
Displaying 11 - 14 of 14